photosensitivity disease: Photosensitivity refers to various symptoms, diseases and conditions caused or aggravated by exposure to sunlight.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
59 |
4. Check minimum number of eventsNone |
59 |
5. Include endpointsNone |
59 |
6. Filter based on genotype QC (FinnGen only) |
59 |
Control definitions (FinnGen only)
- Control exclude
- L12_RADIATIONRELATEDSKIN
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L57
- Name in latin
- Poikiloderm[i]a Civatte
Similar endpoints
↥List of similar endpoints to
Poikiloderma of Civatte
based on the number of shared cases.
Similar with more cases:
- Skin changes due to chronic exposure to nonionizing radiation
- Radiation-related disorders of the skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 307 | 186 | 121 |
| Only index persons | 294 | 181 | 113 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | - | 54.65 | 53.29 |
| Only index persons | 53.91 | 54.48 | 52.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 59 | 43 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 53.98 | 53.01 | 56.57 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 53
- Matched controls
- 531
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L57.3
ICD-10 Finland
Poikiloderma of Civatte
+∞
75.9
53
*
L57.0
ICD-10 Finland
Actinic keratosis
17.2
6.7
10
7
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
21
5.53
4.72
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
11
8.20
4.00
3.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
24
111
2.96
3.80
4.8
4.4
—
1.0
—
0
15
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
99
2.95
3.63
1.5
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
74
3.06
3.46
1.3
1.4
titre
186.7
794.3
—
6
14
(3000494) Fungus identified in Specimen by Culture
14
51
3.29
3.26
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
29
3.95
3.21
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
5
10.75
3.03
1.4
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
15
63
2.85
2.73
1.5
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
7
7.66
2.60
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
36
3.14
2.33
4.7
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
22
121
2.30
2.29
3.1
3.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
165
2.17
2.17
3.5
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
39
2.88
2.04
1.6
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
73
2.41
2.02
1.4
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
43
322
2.24
1.99
2.5
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
17
3.80
1.89
1.7
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
17
3.80
1.89
1.7
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
17
3.80
1.89
1.7
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
42
2.66
1.79
1.8
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
49
2.53
1.76
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
101
2.13
1.74
4.2
3.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26
169
1.96
1.69
28.1
11.6
inr
1.6
1.2
—
6
58
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26
170
1.95
1.65
2.1
1.9
pmol/l
98.7
106.5
0.52
14
77
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
91
2.04
1.47
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
30
212
1.84
1.47
3.5
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
41
321
1.91
1.43
5.1
3.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
17
3.11
1.39
1.2
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
78
2.04
1.35
2.2
2.5
e6/l
0.3
1.1
—
9
49
(4010399)
8
34
2.56
1.35
1.1
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
5
19
2.78
1.24
50.4
4.8
mmol/l
24.6
25.1
—
5
19
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
67
1.99
1.15
1.2
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
21
2.50
1.11
1.6
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
68
1.96
1.10
9.3
7.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
46
2.13
1.10
1.1
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
30
0.00
1.00
0.0
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
37
2.01
0.97
2.6
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
28
2.27
0.94
42.3
5.0
%
0.5
0.8
—
6
28
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
6
28
2.27
0.94
40.0
5.0
%
1.1
1.5
—
6
28
(3018095) Leukocytes [#/volume] in Urine
23
167
1.62
0.93
4.2
3.4
e6/l
3.5
33.3
0.98
15
124
(3022621) pH of Urine by Test strip
6
31
2.04
0.87
4.0
2.1
—
—
—
0
0
(3015736) pH of Urine
25
188
1.57
0.87
4.7
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
20
143
1.60
0.85
2.6
2.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
47
1.81
0.85
1.1
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
53
1.82
0.80
1.7
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
20
145
1.57
0.80
2.7
2.2
u/l
111.9
108.8
0.06
20
137
(40758558) Short blood count panel - Blood
17
120
1.59
0.75
8.2
7.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
58
1.65
0.74
1.4
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
25
194
1.50
0.73
4.8
3.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
27
1.93
0.70
1.2
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
27
1.93
0.70
50.6
5.3
%
93.2
95.3
—
5
27
(3012544) pH of Venous blood
5
29
1.79
0.65
4.6
3.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
19
0.00
0.61
0.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
99
1.54
0.61
1.4
1.3
u/ml
1.5
8.1
—
5
47
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
23
183
1.42
0.57
5.0
3.8
ng/l
16.4
31.8
0.65
17
119
(3012516) Albumin [Mass/volume] in Urine
17
128
1.46
0.56
2.8
3.0
mg/l
164.5
25.7
—
6
81
(3042936) Bacteria identified in Isolate by Culture
9
63
1.50
0.55
3.2
1.7
—
—
—
0
0
(3019225) pH of Specimen
6
40
1.56
0.53
1.5
5.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
15
112
1.45
0.51
1.3
1.3
u/ml
0.6
1.0
—
5
35
(42870588) Differential panel, method unspecified - Blood
19
150
1.39
0.48
8.7
4.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
50
1.45
0.47
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
16
124
1.40
0.45
3.0
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
31
1.67
0.44
53.4
4.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
9
65
1.45
0.41
1.1
2.5
g/l
2.3
2.4
—
9
58
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
87.4
—
0
17
(1761868) Lipid panel - Serum or Plasma
15
187
0.73
0.40
4.9
2.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
10
75
1.40
0.33
1.1
2.5
umol/l
13.2
12.9
—
10
68
(3019309) Folate [Moles/volume] in Red Blood Cells
11
87
1.32
0.26
1.2
1.7
nmol/l
1075.1
1413.2
0.95
11
69
(3002582) Erythrocytes [#/volume] in Urine
17
144
1.25
0.26
3.8
2.8
e6/l
12.9
44.7
0.74
11
115
(3020682) Albumin/Creatinine [Ratio] in Urine
16
135
1.25
0.25
3.3
3.7
mg/mmol
13.2
4.6
—
5
88
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
38
1.34
0.24
1.4
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
24
214
1.20
0.22
10.4
5.1
%
0.6
0.7
0.24
24
198
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
48
1.28
0.21
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(4035726)
6
50
1.22
0.20
2.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.1
—
22.7
—
0
14
(3003694) ABO and Rh group [Type] in Blood
11
131
0.80
0.19
1.5
1.4
—
—
—
0
0
(3013512) EKG study
16
139
1.21
0.19
5.3
3.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
5
68
0.71
0.18
29.4
21.0
—
1.1
—
0
15
(3009542) Hematocrit [Volume Fraction] of Blood
44
460
0.83
0.18
26.8
13.0
%
35.8
40.2
0.88
29
345
(3018418) pH of Serum or Plasma
16
140
1.20
0.17
4.3
4.5
—
7.4
—
0
26
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
20
179
1.18
0.17
2.5
2.7
u/l
51.3
55.0
0.28
20
168
(40760892) CBC W Ordered Manual Differential panel - Blood
15
133
1.17
0.13
5.1
4.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
73
1.11
0.08
1.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
52
508
1.20
0.07
20.9
13.4
mg/l
28.2
21.0
0.74
44
386
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
109
1.13
0.07
4.1
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
24
228
1.09
0.06
10.8
5.1
%
29.4
29.9
0.10
24
211
(3018010) Neutrophils/100 leukocytes in Blood
24
228
1.09
0.06
10.8
4.9
%
57.0
55.5
0.34
24
215
(3044889) 12 lead EKG panel
35
359
0.94
0.03
6.1
3.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
24
232
1.06
0.02
5.7
4.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
41
417
0.94
0.01
23.6
15.9
%
13.5
13.6
0.22
41
411
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
48
479
1.01
0.00
15.3
11.9
ml/min/173m2
82.9
82.1
0.10
36
397
(3041096) Erythrocytes [Presence] in Urine by Automated
15
149
1.01
0.00
3.8
3.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15
151
0.99
0.00
4.1
2.0
—
—
—
0
0
(44790047)
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
7.7
—
0
5
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
53
524
1.11
0.00
17.7
12.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.8
—
4.6
—
0
8
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.8
—
59.6
—
0
8
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
5.7
—
27.0
—
0
7
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806118)
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790048)
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
9
0.00
0.00
0.0
2.1
—
8.9
—
0
9
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790049)
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
12.1
—
0
7
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
91.8
—
0
5
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
9
0.00
0.00
0.0
2.1
—
4.9
—
0
9
(4281824)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_POIKOLOCIVAT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have L12_POIKOLOCIVAT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: L12_POIKOLOCIVAT – Poikiloderma of Civatte
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data